Back

Two years of lettuce yield gains at Jepco

Jepco, UK | Jan 2024-Feb 2026
Deep water culture
Peat substrate
Overture® A & Overture® B
Jepco and Concert Bio holding a bottle of Overture in Jepco's lettuce glasshouse
Leafy greens
Jepco logo

462,000

Plants weighed
Across over two years of R&D and production-scale trials

25

Months of data
Performance data from first R&D trial to latest annual review in February 2026

+23.75%

Average performance
Reported at Jepco's February 2026 annual review

Summary

Jepco grows lettuce for food service all year round in a 1.4-hectare glasshouse in Essex, UK. They use a Dry Hydroponics floating raft system in 14 ponds of recirculating water. Jepco pride themselves on their consistent, year-round lettuce production, and are responsible for the majority of the UK's sandwich production needs (a famously serious matter here).

Jepco and their team have been one of our closest partners. Working with General Manager Jonathan Dove and Development Manager Richard Pett gave us access to their trial space, their production records and their honest feedback. Both have decades of experience in indoor growing. Overture®'s consistency and performance with growers all over the world was in large part made possible thanks to the things we learned working in collaboration with them.

Jepco began by trialling Overture® A and B in several trials at their Kirton R&D site. Their R&D trials consistently showed the best performance with Overture® A. Following those successes, they then began onboarding at their main production site, and in November 2024 Jepco became Concert Bio’s first UK customer.

Through the winter of 2024/25, Concert Bio worked closely with Jepco to establish how they and large-scale commercial growers like them could get the best performance out of Overture®. They applied the microbes by spraying at sowing, then again at transplant using their spray boom. Untreated batches were kept back as controls, and Jepco compared treated and untreated batches in their own production records.

First trials at their main production site didn't show an improvement. We therefore carried out a series of adjustments. This eventually enabled Jepco to achieve results comparable to what they had seen in their R&D trials. In 2025, they confirmed that Overture®'s effect wasn't just visible in the data: their staff could easily tell the difference between treated and untreated plants.

Figure 1
R&D trials at Jepco Kirton, mean fresh head weight vs untreated: Trial 01 (Multigreen 185, BASF Nunhems, two applications) Overture A +12.0%, Overture B +20.0%; Trial 02 (Exwink, Rijk Zwaan) one application Overture A +10.2%, Overture B -1.0%; two applications Overture A +17.1%, Overture B +7.9%
Figure 2
Yield uplift from Overture A at Jepco's H2 glasshouse: first trials late 2024 -1.4%; second trials Jan 2025 +1.9%; spring deployment Jan to Mar 2025 +9.7%; 12-month average Feb 2026 +23.75%
Figure 3
21-day moving average of yield uplift from Overture A on Multigreen 185 at Jepco, 29 January to 14 March 2025, between +6.1% and +15.2%
Jonathan Dove, General Manager, Jepco

“I’ve been growing under glass for over forty years and I’ve seen plenty of products with big promises. Concert Bio were the first people who wanted to understand what was living in our system and work with it. We’ve learned a lot together and the product has got better as we’ve gone along. Even before we looked at the numbers, my staff could see the difference in the crop.”

Jonathan Dove
General Manager, Jepco
Trial details
Location
Kirton & Essex, UK
Trial period
Jan 2024-Feb 2026
Crop
Lettuce
Variety
Multigreen 185 (BASF Nunhems), Exwink (Rijk Zwaan)
System
Deep water culture (DWC)
Substrate
Peat
Product
Overture® A & B
Application method
Multiple trialled, spray at sowing + transplant found to be optimal
Application frequency
Multiple trialled, two applications optimal

Conclusions

Jepco's onboarding with Overture® began with R&D trials at their Kirton site in 2024, where both products increased head weight compared with untreated plants. In R&D Trial 01 (Multigreen 185, BASF Nunhems), two applications of Overture® A gave +12.0% and Overture® B +20.0%. In R&D Trial 02 (Exwink, Rijk Zwaan), a single application gave +10.2% with Overture® A and -1.0% with Overture® B, rising to +17.1% and +7.9% with two applications. It was clear from these results that Overture® A was more consistent for Jepco, and that two applications improved performance.

In late 2024, Jepco moved the trials to their main production site. These got off to a rocky start: in our first batch we averaged -1.4%. This first trial helped us identify several technical issues with Overture® application. In their second round of trials in January 2025, we corrected those, adding a second spray at transplant and treating whole sowings. Results turned positive, at +1.9%, even in the low-light weeks of late January.

Over the rest of spring, from January to March 2025, we continued adjusting applications. By the end of spring Overture® A had increased yield by +9.7% on average across the 33 treated vs untreated comparisons shown in Figure 3. Confident that applications were now working well, from 10 February Jepco moved all of their sowings onto Overture® A, keeping several thousand plants a week untreated as controls. This meant we could continue to monitor performance.

In early 2026, we conducted a 12-month review of this data. After further tuning, Jepco reported their average yield improvement on Multigreen 185 over those 12 months was +23.75%, a stand-out result and testament to years of learning together. Jepco has since signed a supply agreement for routine use of Overture®.

READ ON

More case studies

Ready to take control of your plant microbiome?

Get in touch to get started.

Backed by real world data

Trusted by growers

Science-led, grower-focused

Get access

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.